148 related articles for article (PubMed ID: 38266129)
1. Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry.
Romiti GF; Corica B; Mei DA; Frost F; Bisson A; Boriani G; Bucci T; Olshansky B; Chao TF; Huisman MV; Proietti M; Lip GYH
Europace; 2023 Dec; 26(1):. PubMed ID: 38266129
[TBL] [Abstract][Full Text] [Related]
2. Implications of Clinical Risk Phenotypes on the Management and Natural History of Atrial Fibrillation: A Report From the GLORIA-AF.
Romiti GF; Proietti M; Corica B; Bonini N; Boriani G; Huisman MV; Lip GYH;
J Am Heart Assoc; 2023 Oct; 12(20):e030565. PubMed ID: 37815118
[TBL] [Abstract][Full Text] [Related]
3. Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.
Bucci T; Romiti GF; Shantsila A; Teo WS; Park HW; Shimizu W; Corica B; Proietti M; Tse HF; Chao TF; Frost F; Lip GYH;
J Am Heart Assoc; 2024 Apr; 13(7):e032785. PubMed ID: 38533983
[TBL] [Abstract][Full Text] [Related]
4. Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry.
Romiti GF; Corica B; Mei DA; Bisson A; Boriani G; Olshansky B; Chao TF; Huisman MV; Proietti M; Lip GYH;
BMC Med; 2024 Apr; 22(1):151. PubMed ID: 38589864
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry.
Corica B; Romiti GF; Proietti M; Mei DA; Boriani G; Chao TF; Olshansky B; Huisman MV; Lip GYH;
Mayo Clin Proc; 2024 Jun; 99(6):927-939. PubMed ID: 37632485
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study.
Graul EL; Nordon C; Rhodes K; Menon S; Al Ammouri M; Kallis C; Ioannides AE; Whittaker HR; Peters NS; Quint JK
BMC Pulm Med; 2024 May; 24(1):221. PubMed ID: 38704538
[TBL] [Abstract][Full Text] [Related]
7. Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry.
Romiti GF; Corica B; Proietti M; Mei DA; Frydenlund J; Bisson A; Boriani G; Olshansky B; Chan YH; Huisman MV; Chao TF; Lip GYH;
EClinicalMedicine; 2023 Sep; 63():102039. PubMed ID: 37753446
[TBL] [Abstract][Full Text] [Related]
8. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
9. Multimorbidity in atrial fibrillation for clinical implications using the Charlson Comorbidity Index.
Jung M; Yang PS; Kim D; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Pak HN; Lee MH; Joung B
Int J Cardiol; 2024 Mar; 398():131605. PubMed ID: 38000669
[TBL] [Abstract][Full Text] [Related]
10. Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.
Anjum M; Ariansen I; Hjellvik V; Selmer R; Kjerpeseth LJ; Skovlund E; Myrstad M; Ellekjær H; Christophersen IE; Tveit A; Berge T
Eur Heart J; 2024 Jan; 45(1):57-66. PubMed ID: 37995254
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.
Durheim MT; Holmes DN; Blanco RG; Allen LA; Chan PS; Freeman JV; Fonarow GC; Go AS; Hylek EM; Mahaffey KW; Pokorney SD; Reiffel JA; Singer DE; Peterson ED; Piccini JP
Heart; 2018 Nov; 104(22):1850-1858. PubMed ID: 29875139
[TBL] [Abstract][Full Text] [Related]
12. Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.
Grymonprez M; Carnoy L; Capiau A; Boussery K; Mehuys E; De Backer TL; Steurbaut S; Lahousse L
Eur Heart J Cardiovasc Pharmacother; 2023 Dec; 9(8):722-730. PubMed ID: 37791408
[TBL] [Abstract][Full Text] [Related]
13. Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF Registry.
Romiti GF; Proietti M; Bonini N; Ding WY; Boriani G; Huisman MV; Lip GYH;
EClinicalMedicine; 2023 Jan; 55():101757. PubMed ID: 36457650
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
Romiti GF; Corica B; Pipitone E; Vitolo M; Raparelli V; Basili S; Boriani G; Harari S; Lip GYH; Proietti M;
Eur Heart J; 2021 Sep; 42(35):3541-3554. PubMed ID: 34333599
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in clinical features, utilization of oral anticoagulant agents, and 1-year outcome in Middle Eastern patients with atrial fibrillation.
Alrabadi N; Al-Nusair M; Haddad R; Alghizzawi BS; Al-Nusair N; Alhaj Mohammad S; Shteiwi SM; El-Zubi MK; Marie Z; Alnsour A; Jarrah M; Alzoubi KH; Hammoudeh A
Curr Med Res Opin; 2024 May; 40(5):745-752. PubMed ID: 38507072
[TBL] [Abstract][Full Text] [Related]
16. Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease.
Vlachopoulou D; Balomenakis C; Kartas A; Samaras A; Papazoglou AS; Moysidis DV; Barmpagiannos K; Kyriakou M; Papanastasiou A; Baroutidou A; Vouloagkas I; Tzikas A; Giannakoulas G
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176504
[No Abstract] [Full Text] [Related]
17. Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study.
Huang B; Yang Y; Zhu J; Liang Y; Zhang H; Tian L; Shao X; Wang J
J Am Med Dir Assoc; 2014 Aug; 15(8):576-81. PubMed ID: 24894999
[TBL] [Abstract][Full Text] [Related]
18. Associations of prior pulmonary tuberculosis with the incident COPD: a prospective cohort study.
Zeng Z; Chen H; Shao Z; Guan Y; Zhan Y; Cao X; Li S; Hao X
Ther Adv Respir Dis; 2024; 18():17534666241239455. PubMed ID: 38529640
[TBL] [Abstract][Full Text] [Related]
19. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
[TBL] [Abstract][Full Text] [Related]
20. Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III.
Romiti GF; Proietti M; Bonini N; Ding WY; Boriani G; Huisman MV; Lip GYH;
Thromb Haemost; 2022 Dec; 122(12):2030-2041. PubMed ID: 36037828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
